Oral Abstract Session
Glomerular Precision Nephrology: Novel Mechanisms, Biomarkers, and Therapeutic Targets
November 06, 2025 | 04:30 PM - 06:00 PM
Location: Room 310A, Convention Center
Session Description
Oral Abstract Session
Note: Continuing education credits are not being offered for this session.
Learning Pathway(s)
- Glomerular Diseases
 
Moderators
Presentations
- Single-Cell Multiomics Analysis of Human Kidney Diseases
04:30 PM - 04:40 PM
 - Downregulation of PARD6B Is Associated with Irreversible Podocyte Damage in FSGS
04:40 PM - 04:50 PM
 - Nephrin Trafficking in the Mouse Model of Experimental Autoimmune Nephrotic Syndrome
04:50 PM - 05:00 PM
 - Targeting of CLDN1 Reduces Kidney Injury and Macrophage Infiltration in FSGS
05:00 PM - 05:10 PM
 - A Novel Tool to Study Glomerular Endothelial Cell Biology
05:10 PM - 05:20 PM
 - Kidney-Specific Four-Protein Index Outperforms Conventional Measures for Detecting Early Kidney Damage in Lupus Nephritis and Diabetic Kidney Disease
05:20 PM - 05:30 PM
 - Change in Soluble Biomarker Levels in Patients with IgAN: Analysis of the Phase 2 Trial of Ravulizumab (SANCTUARY)
05:30 PM - 05:40 PM
 - Integration of Pathomic Signatures and Spatial Transcriptomics Reveals Tubular Morphometric Trajectories and Enables Patient Stratification in Minimal Change Disease (MCD)/FSGS
05:40 PM - 05:50 PM
 - Senescence as an Underlying Mechanism of Podocyte Injury in Preeclampsia
05:50 PM - 06:00 PM